About
Jonathan is an expert in computation of the structure, function and interactions of proteins (receptors, transporters, enzymes etc.) at whole genome / proteome scale, and linking this to health and disease and drug discovery. He heads up a research group and spin-out company at Swansea University Medical School, working on innovative academic research and commercial R&D in Structural Bioinformatics, applied to a broad range of biological problems, including a current Innovate UK funded project focused on development of an antiviral drug screening platform for Covid-19. The research is getting ahead of the virus by modelling hypothetical variants and structural changes, targeting new strains before they happen.